Skip to main content
Clinical Trials/CTRI/2019/01/017055
CTRI/2019/01/017055RecruitingPhase 3

Comparision of Endoscopic and Laparoscopic removal of Large Bile Duct Stone: A Randomized Controlled Trial

Department of Gastroenterology and Department of Surgery1 site in 1 country40 target enrollmentStarted: January 15, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
The primary outcome will be a composite of complete removal of stone in the bile duct by laproscopic CBD exploration (LCE) or endoscopic method, need of more than two attempts of ERCP for bile duct clearance or occurrence of major complication.

Study Overview

Brief Summary

Gall bladder stones are associated with common bile duct (CBD) stones in 7-12% of patients. The preferred method of removal of bile duct stone is endoscopic retrograde cholangiopancreatography (ERCP). However the success rate of bile duct stone removal decreases with increase in size of stone especially ≥ 1.5 cm stones as well as the number of procedures. On the contrary laparoscopic CBD exploration (LCE) is a single stage procedure with the advantage of having cholecystectomy in same setting, but it is associated with complications such as bile leak, conversion to open surgery and prolonged hospitalization. It is not clear which is better for large CBD stone (≥ 1.5 cm). Our aim to compare both the modalities in patients with CBD stone of size 1.5 cm or more.

Study Design

Study Type
Interventional
Allocation
Permuted block randomization, fixed
Masking
Open Label

Eligibility Criteria

Ages
18.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients with a common bile duct stone of size 1.5 cm or more detected on a magnetic resonance cholangiopancreatography (MRCP) with or without gall stones, both pre and post cholecystectomy will be included in the study.

Exclusion Criteria

  • •1.Presence of acute cholecystitis 2.Presence of acute cholangitis 3.Patients with obstructive jaundice with a serum bilirubin level higher than 10 mg/dl 4.Patients with a CBD diameter less than 10 mm 5.Patients with a history of hepatobiliary surgery other than cholecystectomy 6.Patient with uncorrectable coagulopathy 7.Patient with American Society Anaeathesiology (ASA) class 3 or more 8.Patient refusal to give consent.

Outcomes

Primary Outcomes

The primary outcome will be a composite of complete removal of stone in the bile duct by laproscopic CBD exploration (LCE) or endoscopic method, need of more than two attempts of ERCP for bile duct clearance or occurrence of major complication.

Time Frame: at 1 month

Secondary Outcomes

  • 1. Complications of the intervention(2. Procedure time in minutes)

Investigators

Sponsor
Department of Gastroenterology and Department of Surgery
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials